Erin Davis

Dr. Erin Davis

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Minerva Endocrinology
Verified
Journal Article
Closed access
EDErin Davis
Erin Davis
JPJennifer D. Peck
Jennifer D. Peck
KHKarl R. Hansen
Karl R. Hansen
BNBarbara R. Neas
Barbara R. Neas
LCLaTasha B. Craig
LaTasha B. Craig
Article: Associations between vitamin D levels and polycystic ovary syndrome phenotypes - Minerva Endocrinologica 2019 June;44(2):176-84 - Minerva Medica - Journals

15 July 2022 in Environmental Research
Verified
Journal Article
Closed access
WCWei-Jen Chen
Wei-Jen Chen
CRCandace Robledo
Candace Robledo
EDErin Davis
Erin Davis
JGJean R. Goodman
Jean R. Goodman
CXChao Xu
Chao Xu
JPJennifer D. Peck
Jennifer D. Peck

3 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
JRJessica Reese
Jessica Reese
EDErin Davis
Erin Davis
PHPryce Holloway
Pryce Holloway
AFAmanda Fretts
Amanda Fretts
TATauqeer Ali
Tauqeer Ali
JPJennifer D. Peck
Jennifer D. Peck
Background: Vitamin D deficiency (VDD) may be associated with chronic health issues, including markers of liver disease; however, evidence in American Indian adolescents is limited. Therefore, we aimed to evaluate the relationship between VDD in American Indian adolescents and markers of liver disease, including both serum and magnetic resonance imaging (MRI) markers. Methods: The Strong Heart Family Study (SHFS) is a multicenter, family-based, prospective cohort study among American Indians. We evaluated SHFS participants who were <20 years old at baseline (2001–2003; n = 308), defined VDD as hydroxyvitamin-D (25[OH]D) ≤ 20 ng/mL and calculated the Hepatic Steatosis Index (HSI). In 2006–2009, we measured follow-up serum markers (n = 269, median follow-up = 5.8 years, range = 3.0–8.5), and in 2018–2020, we collected MRI markers of hepatic steatosis and fibrosis (n = 33, median follow-up = 16.7 years, range = 15.3–18.1). Results: At baseline, a greater proportion of those with VDD had HSI > 36 (64.5% with VDD; p = 0.002). For participants who reported consuming alcohol, serum alkaline phosphate (ALP) increased at follow-up, which was higher for those with versus without VDD (beta = 12.24, 95% CI = 1.23–23.24). For participants who reported not consuming alcohol, ALP decreased but was not different between the VDD groups. The MRI-proton density fat fraction was higher in those with (median = 11.0%, IQR = 7.7–19.2%) versus without (median = 4.4, IQR = 1.8–6.3%) VDD at baseline (p < 0.001). Conclusions: VDD may be associated with markers of liver disease in American Indian adolescents. After 5.5 years, VDD was associated with increasing ALP in those who consume alcohol, while controlling for adiposity and other covariates. After 17 years of follow-up, VDD was associated with increased liver MRI-PDFF.